Alfredo Ibarra-Sánchez

Dr. Alfredo Ibarra-Sánchez

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2022 in Cells
Verified
Journal Article
Open access
PDF file
Deisy Segura-VillalobosDeisy Segura-Villalobos
Deisy Segura-Villalobos
IRItzel G. Ramírez-Moreno
Itzel G. Ramírez-Moreno
LALizbeth Magnolia Martinez Aguilar
Lizbeth Magnolia Martinez Aguilar
Alfredo Ibarra-SánchezAlfredo Ibarra-Sánchez
Alfredo Ibarra-Sánchez
J. Omar Muñoz-BelloJ. Omar Muñoz-Bello
J. Omar Muñoz-Bello
CGClaudia González-Espinosa
Claudia González-Espinosa
Mast cells (MCs) are tissue-resident immune cells that are important players in diseases associated with chronic inflammation such as cancer. Since MCs can infiltrate solid tumors and promote or limit tumor growth, a possible polarization of MCs to pro-tumoral or anti-tumoral phenotypes has been proposed and remains as a challenging research field. Here, we review the recent evidence regarding the complex relationship between MCs and tumor cells. In particular, we consider: (1) the multifaceted role of MCs on tumor growth suggested by histological analysis of tumor biopsies and studies performed in MC-deficient animal models; (2) the signaling pathways triggered by tumor-derived chemotactic mediators and bioactive lipids that promote MC migration and modulate their function inside tumors; (3) the possible phenotypic changes on MCs triggered by prevalent conditions in the tumor microenvironment (TME) such as hypoxia; (4) the signaling pathways that specifically lead to the production of angiogenic factors, mainly VEGF; and (5) the possible role of MCs on tumor fibrosis and metastasis. Finally, we discuss the novel literature on the molecular mechanisms potentially related to phenotypic changes that MCs undergo into the TME and some therapeutic strategies targeting MC activation to limit tumor growth.

2 August 2013 in Journal of Hematology & Oncology
Verified
Journal Article
Open access
PDF file
GJGuillermina Yanek Jiménez-Andrade
Guillermina Yanek Jiménez-Andrade
Alfredo Ibarra-SánchezAlfredo Ibarra-Sánchez
Alfredo Ibarra-Sánchez
DGDiana González
Diana González
MLMonica Lamas
Monica Lamas
CGClaudia González-Espinosa
Claudia González-Espinosa
Background: High concentrations of plasmatic IgE have been related to distinct systemic inflammatory conditions that frequently predispose individuals to hypersensitivity reactions. Although effects of IgE have been suggested to relay on the low-intensity activation of distinct effector elements of the immune system, such as mast cells (MC), experimental evidence on the role of IgE-induced production of inflammatory mediators on specific pathologies is scarce. MC are an important component in tumor microenvironment where they seem to secrete a number of immunomodulatory and angiogenic mediators, such as the Vascular Endothelial Growth Factor (VEGF) by not well-described mechanisms. In this work, we investigated the effect of monomeric IgE (in the absence of antigen) on the production of VEGF in MC, analyzed if monomeric IgE could exacerbate the pro-tumorigenic properties of that cell type and characterized some of the molecular mechanisms behind the effects of IgE on VEGF production and tumor growth.Methods: Forin vitrostudies, murine bone marrow-derived mast cells (BMMCs) were used. Pharmacological inhibitors and phosphorylation of key elements controlling VEGF secretion and protein translation were used to characterize the mechanism of VEGF production triggered by IgE.In vivo, the effect of a single i.v. administration of monomeric IgE on B16 melanoma tumor weight, intratumoral blood vessel formation and tumor-associated MC was assessed in four groups of mice: MC-proficient (WT), MC-deficient (Wsh), Wsh reconstituted with MC derived from WT mice (Wsh Rec WT) and Wsh reconstituted with MC derived from Fyn −/− mice (Wsh Rec Fyn −/−).Results: Monomeric IgE induced VEGF secretion through a Fyn kinase-dependent mechanism and modulatedde novoprotein synthesis modifying the activity of the translational regulator 4E-BP1 in BMMCs.In vivo, monomeric IgE increased melanoma tumor growth, peritumoral MC and blood vessel numbers in WT but not in Wsh mice. The positive effects of IgE on melanoma tumor growth were reproduced after reconstitution of Wsh mice with WT but not with Fyn −/− BMMCs.Conclusion: Our data suggest that monomeric IgE, in the absence of antigen, induces VEGF production in MC andin vivocontributes to melanoma tumor growth through a Fyn kinase-dependent mechanism.

15 June 2016 in The Journal of Immunology
Verified
Journal Article
Closed access
AMAlejandro Martín-Ávila
Alejandro Martín-Ávila
JMJaciel Medina-Tamayo
Jaciel Medina-Tamayo
Alfredo Ibarra-SánchezAlfredo Ibarra-Sánchez
Alfredo Ibarra-Sánchez
GVGenaro Vázquez-Victorio
Genaro Vázquez-Victorio
JCJorge Ivan Castillo-Arellano
Jorge Ivan Castillo-Arellano
CGClaudia González-Espinosa
Claudia González-Espinosa
Mast cells produce proinflammatory cytokines in response to TLR4 ligands, but the signaling pathways involved are not fully described. In this study, the participation of the Src family kinase Fyn in the production of TNF after stimulation with LPS was evaluated using bone marrow–derived mast cells from wild-type and Fyn-deficient mice. Fyn−/− cells showed higher LPS-induced secretion of preformed and de novo–synthesized TNF. In both cell types, TNF colocalized with vesicle-associated membrane protein (VAMP)3-positive compartments. Addition of LPS provoked coalescence of VAMP3 and its interaction with synaptosomal-associated protein 23; those events were increased in the absence of Fyn. Higher TNF mRNA levels were also observed in Fyn-deficient cells as a result of increased transcription and greater mRNA stability after LPS treatment. Fyn−/− cells also showed higher LPS-induced activation of TAK-1 and ERK1/2, whereas IκB kinase and IκB were phosphorylated, even in basal conditions. Increased responsiveness in Fyn−/− cells was associated with a lower activity of protein phosphatase 2A (PP2A) and augmented activity of protein kinase C (PKC)α/β, which was dissociated from PP2A and increased its association with the adapter protein neuroblast differentiation–associated protein (AHNAK, desmoyokin). LPS-induced PKCα/β activity was associated with VAMP3 coalescence in WT and Fyn-deficient cells. Reconstitution of MC-deficient Wsh mice with Fyn−/− MCs produced greater LPS-dependent production of TNF in the peritoneal cavity. Our data show that Fyn kinase is activated after TLR4 triggering and exerts an important negative control on LPS-dependent TNF production in MCs controlling the inactivation of PP2Ac and activation of PKCα/β necessary for the secretion of TNF by VAMP3+ carriers.

27 March 2020 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
MRMarian Jesabel Perez Rodrìguez
Marian Jesabel Perez Rodrìguez
Alfredo Ibarra-SánchezAlfredo Ibarra-Sánchez
Alfredo Ibarra-Sánchez
ARAbraham Román-Figueroa
Abraham Román-Figueroa
FPFrancisca Perez-Severiano
Francisca Perez-Severiano
CGClaudia González-Espinosa
Claudia González-Espinosa
Background: Huntington’s disease (HD) is caused by the expression of a mutated variant of Huntingtin (mHtt), which results in the complex pathology characterized by a defective function of the nervous system and altered inflammatory responses. While the neuronal effects of mHtt expression have been extensively studied, its effects on the physiology of immune cells have not been fully described. Mast cells (MCs) are unique tissue-resident immune cells whose activation has been linked to protective responses against parasites and bacteria, but also to deleterious inflammatory allergic reactions and, recently, to neurodegenerative diseases.Methods: Bone marrow-derived mast cells (BMMCs) were obtained from wild-type (WT-) and mHtt-expressing (R6/1) mice to evaluate the main activation parameters triggered by the high-affinity IgE receptor (FcεRI) and the Toll-like receptor (TLR) 4. Degranulation was assessed by measuring the secretion of β-hexosaminidase, MAP kinase activation was detected by Western blot, and cytokine production was determined by RT-PCR and ELISA. TLR-4 receptor and Htt vesicular trafficking was analyzed by confocal microscopy. In vivo, MC-deficient mice (c-KitWsh/Wsh) were intraperitonally reconstituted with WT or R6/1 BMMCs and the TLR4-induced production of the tumor necrosis factor (TNF) was determined by ELISA. A survival curve of mice treated with a sub-lethal dose of bacterial lipopolysaccharide (LPS) was constructed.Results: R6/1 BMMCs showed normal β-hexosaminidase release levels in response to FcεRI, but lower cytokine production upon LPS stimulus. Impaired TLR4-induced TNF production was associated to the lack of intracellular dynamin-dependent TLR-4 receptor trafficking to perinuclear regions in BMMCs, a diminished ERK1/2 and ELK-1 phosphorylation, and a decrease inc-fosand TNF mRNA accumulation. R6/1 BMMCs also failed to produce TLR4-induced anti-inflammatory cytokines (like IL-10 and TGF-β). The detected defects were also observed in vivo, in a MCs-dependent model of endotoxemia. R6/1 andc-KitWsh/Wshmice reconstituted with R6/1 BMMCs showed a decreased TLR4-induced TNF production and lower survival rates to LPS challenge than WT mice.Conclusions: Our data show that mHtt expression causes an impaired production of pro- and anti-inflammatory mediators triggered by TLR-4 receptor in MCs in vitro and in vivo, which could contribute to the aberrant immunophenotype observed in HD.

1 October 2010 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
JGJonathan García-Román
Jonathan García-Román
Alfredo Ibarra-SánchezAlfredo Ibarra-Sánchez
Alfredo Ibarra-Sánchez
MLMónica Lamas
Mónica Lamas
CGClaudia González-Espinosa
Claudia González-Espinosa

13 July 2010 in Inflammation Research
Verified
Journal Article
Closed access
PDF file
JMJaciel Medina-Tamayo
Jaciel Medina-Tamayo
Alfredo Ibarra-SánchezAlfredo Ibarra-Sánchez
Alfredo Ibarra-Sánchez
APAlejandro Padilla-Trejo
Alejandro Padilla-Trejo
CGClaudia González-Espinosa
Claudia González-Espinosa